StonvexLoading…
StonvexStonvexStonvexCore line items from TT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $21.32B | $19.84B | $17.68B | $15.99B |
Operating Income | $3.97B | $3.50B | $2.89B | $2.42B |
Net Income | $2.92B | $2.57B | $2.02B | $1.76B |
EPS (Diluted) | $12.98 | $11.24 | $8.77 | $7.48 |
Total Assets | $21.42B | $20.15B | $19.39B | $18.08B |
Total Liabilities | $12.82B | $12.66B | $12.37B | $11.98B |
Cash & Equivalents | $1.76B | $1.59B | $1.10B | $1.22B |
Free Cash Flow OCF − CapEx | $2.81B | $2.77B | $2.09B | $1.21B |
Shares Outstanding | 224.90M | 249.00M | 251.70M | 253.30M |